Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
PHASE2CompletedINTERVENTIONAL
Enrollment
116
Participants
Timeline
Start Date
July 31, 2004
Primary Completion Date
July 31, 2006
Conditions
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic CancerStage IV Pancreatic Cancer
Interventions
DRUG
triapine
Given IV
Trial Locations (1)
55905
Mayo Clinic, Rochester
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00085371 - Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | Biotech Hunter | Biotech Hunter